BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rathore R, McCallum JE, Varghese E, Florea AM, Büsselberg D. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs). Apoptosis 2017;22:898-919. [PMID: 28424988 DOI: 10.1007/s10495-017-1375-1] [Cited by in Crossref: 141] [Cited by in F6Publishing: 154] [Article Influence: 28.2] [Reference Citation Analysis]
Number Citing Articles
1 Tao Y, Sun XS, Pointreau Y, Le Tourneau C, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Calderon B, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, Gherga E, Nguyen F, Lafond C, Bera G, Calugaru V, Geoffrois L, Chauffert B, Damstrup L, Crompton P, Ennaji A, Gollmer K, Nauwelaerts H, Bourhis J. Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial. Eur J Cancer 2023;183:24-37. [PMID: 36796234 DOI: 10.1016/j.ejca.2022.12.015] [Reference Citation Analysis]
2 Li M, Qian M, Jiang Q, Tan B, Yin Y, Han X. Evidence of Flavonoids on Disease Prevention. Antioxidants (Basel) 2023;12. [PMID: 36830086 DOI: 10.3390/antiox12020527] [Reference Citation Analysis]
3 Yang N, Kong B, Zhu Z, Huang F, Zhang L, Lu T, Chen Y, Zhang Y, Jiang Y. Recent advances in targeted protein degraders as potential therapeutic agents. Mol Divers 2023;:1-25. [PMID: 36790583 DOI: 10.1007/s11030-023-10606-w] [Reference Citation Analysis]
4 Wolf P. Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer. Front Oncol 2023;13:1124600. [PMID: 36845731 DOI: 10.3389/fonc.2023.1124600] [Reference Citation Analysis]
5 Ferris RL, Harrington K, Schoenfeld JD, Tahara M, Esdar C, Salmio S, Schroeder A, Bourhis J. Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck. Cancer Treat Rev 2023;113:102492. [PMID: 36640618 DOI: 10.1016/j.ctrv.2022.102492] [Reference Citation Analysis]
6 Fiore M, Mosconi M, Bonì F, Parodi A, Salis A, Tasso B, Mastrangelo E, Millo E, Cossu F. New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells. Molecules 2023;28. [PMID: 36615638 DOI: 10.3390/molecules28010446] [Reference Citation Analysis]
7 Feng L, Zhang X, Li W, Wang J, Wang Q, Wang Q, Li M. Proteomics reveals that Di Dang decoction can regulate the Jak2/Stat5 signaling pathway and inhibit apoptosis by reducing the oxidative stress response in rats with acute intracerebral hemorrhagic stroke. Journal of Ethnopharmacology 2023;301:115816. [DOI: 10.1016/j.jep.2022.115816] [Reference Citation Analysis]
8 Li R, Liu M, Yang Z, Li J, Gao Y, Tan R. Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future. Molecules 2022;27. [PMID: 36557960 DOI: 10.3390/molecules27248828] [Reference Citation Analysis]
9 Zhang F, Peng W, Wang T, Zhang J, Dong W, Wang C, Xie Z, Luo H, Liu G. Lnc Tmem235 promotes repair of early steroid-induced osteonecrosis of the femoral head by inhibiting hypoxia-induced apoptosis of BMSCs. Exp Mol Med 2022;54:1991-2006. [PMID: 36380019 DOI: 10.1038/s12276-022-00875-0] [Reference Citation Analysis]
10 Krawiec K, Strzałka P, Czemerska M, Wiśnik A, Zawlik I, Wierzbowska A, Pluta A. Targeting Apoptosis in AML: Where Do We Stand? Cancers 2022;14:4995. [DOI: 10.3390/cancers14204995] [Reference Citation Analysis]
11 Johnson B, Zhuang L, Rath EM, Yuen ML, Cheng NC, Shi H, Kao S, Reid G, Cheng YY. Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response. Cancers (Basel) 2022;14:4784. [PMID: 36230710 DOI: 10.3390/cancers14194784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ju E, Park KA, Shen HM, Hur GM. The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era. Exp Mol Med 2022. [PMID: 36171264 DOI: 10.1038/s12276-022-00847-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Abaza A, Vasavada AM, Sadhu A, Valencia C, Fatima H, Nwankwo I, Anam M, Maharjan S, Amjad Z, Khan S. A Systematic Review of Apoptosis in Correlation With Cancer: Should Apoptosis Be the Ultimate Target for Cancer Treatment? Cureus 2022. [DOI: 10.7759/cureus.28496] [Reference Citation Analysis]
14 Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C. Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo. Med Oncol 2022;39:109. [PMID: 35578067 DOI: 10.1007/s12032-022-01697-w] [Reference Citation Analysis]
15 Huang M, Wang C, Yao Y, Li H, Yao Y, Zhu Y, Cui Y, Yuan Y, Sha J. Mebendazole-Induced Blood-Testis Barrier Injury in Mice Testes by Disrupting Microtubules in Addition to Triggering Programmed Cell Death. Int J Mol Sci 2022;23:4220. [PMID: 35457043 DOI: 10.3390/ijms23084220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Thapa S, A. Rather R, K. Singh S, Bhagat M. Insights into the Role of Defective Apoptosis in Cancer Pathogenesis and Therapy. Regulation and Dysfunction of Apoptosis 2022. [DOI: 10.5772/intechopen.97536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Evren Okur M, I. Siafaka P, Tutar M, Tutar Y. Recent Advancements in Apoptosis-Based Therapeutic Approaches for Cancer Targeting. Regulation and Dysfunction of Apoptosis 2022. [DOI: 10.5772/intechopen.99202] [Reference Citation Analysis]
18 Cetraro P, Plaza-diaz J, Mackenzie A, Abadía-molina F. A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer. Cancers 2022;14:1671. [DOI: 10.3390/cancers14071671] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
19 Labbozzetta M, Poma P, Tutone M, Mccubrey JA, Sajeva M, Notarbartolo M. Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia. Pharmaceuticals 2022;15:356. [DOI: 10.3390/ph15030356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Binder PS, Hashim YM, Cripe J, Buchanan T, Zamorano A, Vangveravong S, Mutch DG, Hawkins WG, Powell MA, Spitzer D. The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09367-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zuo Y, Shen H, Sun F, Li P, Sun J, Kwok RTK, Lam JWY, Tang BZ. Aggregation-Induced Emission Luminogens for Cell Death Research. ACS Bio Med Chem Au 2022;2:236-57. [DOI: 10.1021/acsbiomedchemau.1c00066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Haider M, Elsherbeny A, Pittalà V, Consoli V, Alghamdi MA, Hussain Z, Khoder G, Greish K. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer. IJMS 2022;23:1853. [DOI: 10.3390/ijms23031853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sahyon HAE, Ramadan ENM, Althobaiti F, Mashaly MMA. Anti-proliferative effects of the combination of Sulfamethoxazole and Quercetin via caspase3 and NFkB gene regulation: an in vitro and in vivo study. Naunyn Schmiedebergs Arch Pharmacol 2022;395:227-46. [PMID: 34994822 DOI: 10.1007/s00210-021-02174-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Starska-Kowarska K. Dietary Carotenoids in Head and Neck Cancer-Molecular and Clinical Implications. Nutrients 2022;14:531. [PMID: 35276890 DOI: 10.3390/nu14030531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Deng C, Hu F, Zhao Z, Zhou Y, Liu Y, Zhang T, Li S, Zheng W, Zhang W, Wang T, Ma X. The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance. Front Cell Dev Biol 2021;9:797005. [PMID: 35047507 DOI: 10.3389/fcell.2021.797005] [Reference Citation Analysis]
26 Mohammadhosseinpour S, Ho LC, Fang L, Xu J, Medina-Bolivar F. Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells. Int J Mol Sci 2022;23:1139. [PMID: 35163062 DOI: 10.3390/ijms23031139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Hu F, Deng C, Zhou Y, Liu Y, Zhang T, Zhang P, Zhao Z, Miao H, Zheng W, Zhang W, Wang M, Ma X. Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment‐mediated protein nanocages for enhancing cancer biotherapy. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10290] [Reference Citation Analysis]
28 Tomlinson ML, Zhao M, Barclay EJ, Li J, Li H, Felix J, Hill L, Saalbach G, Rejzek M, Yang D, Zhao Q, Kroon P, Wang W, Bao Y, Howes MR, Tatsis EC, Martin C. Diterpenoids from <i>Scutellaria barbata</i> induce tumour-selective cytotoxicity by taking the brakes off apoptosis. M 2022;1:1-16. [DOI: 10.48130/mpb-2022-0003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Bostan M, Ion G, Mihaila M, Roman V, Constantin C, Neagu MT. Oxidative Stress Player in Head and Neck Cancer Therapy Response. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_39] [Reference Citation Analysis]
30 Lim PT, Goh BH, Lee W. Taxol: Mechanisms of action against cancer, an update with current research. Paclitaxel 2022. [DOI: 10.1016/b978-0-323-90951-8.00007-2] [Reference Citation Analysis]
31 Prasad SB. Cancer and apoptosis. Understanding Cancer 2022. [DOI: 10.1016/b978-0-323-99883-3.00015-9] [Reference Citation Analysis]
32 Kim TW, Lee HG. Apigenin Induces Autophagy and Cell Death by Targeting EZH2 under Hypoxia Conditions in Gastric Cancer Cells. Int J Mol Sci 2021;22:13455. [PMID: 34948250 DOI: 10.3390/ijms222413455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
33 Zhang S, Liu X, Abdulmomen Ali Mohammed S, Li H, Cai W, Guan W, Liu D, Wei Y, Rong D, Fang Y, Haider F, Lv H, Jin Z, Chen X, Mo Z, Li L, Yang S, Wang H. Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers. Autophagy 2021;:1-19. [PMID: 34870550 DOI: 10.1080/15548627.2021.2002108] [Reference Citation Analysis]
34 Wang Y, Yan C, Qi J, Liu C, Yu J, Wang H. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells. Mol Cell Biochem 2021. [PMID: 34716858 DOI: 10.1007/s11010-021-04271-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Li G, Liao M, Li S, You J, Wang J, Lei W, Yang C, Xu H, Xiao H, Chen H. Downregulation of inhibitor of apoptosis protein induces apoptosis and suppresses stemness maintenance in testicular teratoma. Exp Ther Med 2021;22:1399. [PMID: 34675993 DOI: 10.3892/etm.2021.10835] [Reference Citation Analysis]
36 Zhang X, Guo Y, Li H, Han L. FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma. J Cancer 2021;12:6610-9. [PMID: 34659551 DOI: 10.7150/jca.58500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Friedson B, Cooper KF. Cdk8 Kinase Module: A Mediator of Life and Death Decisions in Times of Stress. Microorganisms 2021;9:2152. [PMID: 34683473 DOI: 10.3390/microorganisms9102152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ismail Z, Dam J, Penny C, de Koning CB, Harmse L. Copper-imidazo[1,2-a]pyridines differentially modulate pro- and anti-apoptotic protein and gene expression in HL-60 and K562 leukaemic cells to cause apoptotic cell death. Biochim Biophys Acta Mol Cell Res 2022;1869:119160. [PMID: 34634376 DOI: 10.1016/j.bbamcr.2021.119160] [Reference Citation Analysis]
39 Erekat NS. Apoptosis and its therapeutic implications in neurodegenerative diseases. Clin Anat 2022;35:65-78. [PMID: 34558138 DOI: 10.1002/ca.23792] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis 2021;26:512-33. [PMID: 34510317 DOI: 10.1007/s10495-021-01687-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
41 Neophytou CM, Trougakos IP, Erin N, Papageorgis P. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers (Basel) 2021;13:4363. [PMID: 34503172 DOI: 10.3390/cancers13174363] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
42 Lin W, Sun J, Sadahira T, Xu N, Wada K, Liu C, Araki M, Xu A, Watanabe M, Nasu Y, Huang P. Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer. Int J Biol Sci 2021;17:3255-67. [PMID: 34421363 DOI: 10.7150/ijbs.63125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Fung S, Knoefel WT, Krieg A. Clinicopathological and Prognostic Significance of Inhibitor of Apoptosis Protein (IAP) Family Members in Lung Cancer: A Meta-Analysis. Cancers (Basel) 2021;13:4098. [PMID: 34439255 DOI: 10.3390/cancers13164098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Jiang N, Zhang WQ, Dong H, Hao YT, Zhang LM, Shan L, Yang XD, Peng CL. SMAC exhibits anti-tumor effects in ECA109 cells by regulating expression of inhibitor of apoptosis protein family. World J Clin Cases 2021; 9(19): 5019-5027 [PMID: 34307552 DOI: 10.12998/wjcc.v9.i19.5019] [Reference Citation Analysis]
45 Liu J, Liu X, Wei B, Liu J, Wang Y, Liu H. [Effect of stable overexpression of XAF1 gene on biological characteristics of ovarian cancer A2780 cells]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:760-6. [PMID: 34134965 DOI: 10.12122/j.issn.1673-4254.2021.05.18] [Reference Citation Analysis]
46 Miles MA, Caruso S, Baxter AA, Poon IKH, Hawkins CJ. Smac mimetics can provoke lytic cell death that is neither apoptotic nor necroptotic. Apoptosis 2020;25:500-18. [PMID: 32440848 DOI: 10.1007/s10495-020-01610-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Mu C, Peng RK, Guo CL, Li A, Yang XM, Zeng R, Li YL, Gu J, Ouyang Q. Discovery of sertraline and its derivatives able to combat drug-resistant gastric cancer cell via inducing apoptosis. Bioorg Med Chem Lett 2021;41:127997. [PMID: 33775839 DOI: 10.1016/j.bmcl.2021.127997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Hou H, Su K, Huang C, Yuan Q, Li S, Sun J, Lin Y, Du Z, Ke C, Yuan Z. TRAIL-Armed ER Nanosomes Induce Drastically Enhanced Apoptosis in Resistant Tumor in Combination with the Antagonist of IAPs (AZD5582). Adv Healthc Mater 2021;10:e2100030. [PMID: 33963815 DOI: 10.1002/adhm.202100030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Zhu DL, Shuai LY. Effects of Birinapant on Proliferation and Invasion of MGC-803 Gastric Cancer Cells and Mechanism Underlying These Effects. Bull Exp Biol Med 2021;171:56-61. [PMID: 34050412 DOI: 10.1007/s10517-021-05172-w] [Reference Citation Analysis]
50 Kanno Y, Chen CY, Lee HL, Chiou JF, Chen YJ. Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers. Front Oncol 2021;11:640392. [PMID: 34026617 DOI: 10.3389/fonc.2021.640392] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
51 Hashemi Sheikhshabani S, Amini-Farsani Z, Rahmati S, Jazaeri A, Mohammadi-Samani M, Asgharzade S. Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators. Life Sci 2021;278:119525. [PMID: 33894272 DOI: 10.1016/j.lfs.2021.119525] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
52 Zhang R, Wu T, Zheng P, Liu M, Xu G, Xi M, Yu J. Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage. DNA Repair (Amst) 2021;103:103117. [PMID: 33990030 DOI: 10.1016/j.dnarep.2021.103117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Zhu YX, Jia HR, Duan QY, Wu FG. Nanomedicines for combating multidrug resistance of cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1715. [PMID: 33860622 DOI: 10.1002/wnan.1715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Rajabi S, Maresca M, Yumashev AV, Choopani R, Hajimehdipoor H. The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy. Biomolecules 2021;11. [PMID: 33916780 DOI: 10.3390/biom11040534] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
55 Gerard L, Duvivier L, Gillet JP. Targeting tumor resistance mechanisms. Fac Rev 2021;10:6. [PMID: 33659924 DOI: 10.12703/r/10-6] [Reference Citation Analysis]
56 Machado L, Geara P, Camps J, Dos Santos M, Teixeira-Clerc F, Van Herck J, Varet H, Legendre R, Pawlotsky JM, Sampaolesi M, Voet T, Maire P, Relaix F, Mourikis P. Tissue damage induces a conserved stress response that initiates quiescent muscle stem cell activation. Cell Stem Cell 2021;28:1125-1135.e7. [PMID: 33609440 DOI: 10.1016/j.stem.2021.01.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
57 Yan J, Cao J, Chen Z. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes. BMC Cancer 2021;21:175. [PMID: 33602168 DOI: 10.1186/s12885-021-07886-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Shi W, Lu D, Wu C, Li M, Ding Z, Li Y, Chen B, Lin X, Su W, Shao X, Xia Z, Fang L, Liu K, Li H. Coibamide A kills cancer cells through inhibiting autophagy. Biochem Biophys Res Commun 2021;547:52-8. [PMID: 33592379 DOI: 10.1016/j.bbrc.2021.01.112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
59 Chen Y, Luo X, Zou Z, Liang Y. The Role of Reactive Oxygen Species in Tumor Treatment and its Impact on Bone Marrow Hematopoiesis. Curr Drug Targets 2020;21:477-98. [PMID: 31736443 DOI: 10.2174/1389450120666191021110208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
60 Naimi A, Safaei S, Entezari A, Solali S, Hassanzadeh A. Knockdown of Enhancer of Zeste Homolog 2 Affects mRNA Expression of Genes Involved in the Induction of Resistance to Apoptosis in MOLT-4 Cells. Anticancer Agents Med Chem 2020;20:571-9. [PMID: 32000648 DOI: 10.2174/1871520620666200130091955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Chakraborty S, Mir KB, Seligson ND, Nayak D, Kumar R, Goswami A. Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis. Cancer Metastasis Rev. 2020;. [PMID: 32020420 DOI: 10.1007/s10555-020-09866-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
62 Song H, Guo X, Sun L, Wang Q, Han F, Wang H, Wray GA, Davidson P, Wang Q, Hu Z, Zhou C, Yu Z, Yang M, Feng J, Shi P, Zhou Y, Zhang L, Zhang T. The hard clam genome reveals massive expansion and diversification of inhibitors of apoptosis in Bivalvia. BMC Biol 2021;19:15. [PMID: 33487168 DOI: 10.1186/s12915-020-00943-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
63 Zhao T, Wan Z, Sambath K, Yu S, Uddin MN, Zhang Y, Belfield KD. Regulating Mitochondrial pH with Light and Implications for Chemoresistance. Chemistry 2021;27:247-51. [PMID: 33048412 DOI: 10.1002/chem.202004278] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Lan M, Lu W, Zou T, Li L, Liu F, Cai T, Cai Y. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy. Cell Mol Life Sci 2021;78:2105-29. [PMID: 33386887 DOI: 10.1007/s00018-020-03696-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
65 Barbosa PPDS, Araújo FND, Almeida JMD, Gadelha TS. Leguminosae Lectins as Biological Tools in Medical Research: a Review. Braz arch biol technol 2021;64. [DOI: 10.1590/1678-4324-2021200170] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Chang Y, Cheung CHA. An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment. Applied Sciences 2021;11:335. [DOI: 10.3390/app11010335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
67 Noonan AM, Cousins A, Anderson D, Zeligs KP, Bunch K, Hernandez L, Shibuya Y, Goldlust IS, Guha R, Ferrer M, Thomas CJ, Annunziata CM. Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer. Cancers (Basel) 2020;12:E3784. [PMID: 33334024 DOI: 10.3390/cancers12123784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Lan H, Fang-liang Z, Pan Z, Xian-wen W, Yi-lan J, Ying-chun H, Duan-fang L, De-liang C. Yi Qi Jie Du Formula and Salinomycin Combination Treatment Mediates Nasopharyngeal Carcinoma Stem Cell Proliferation, Migration and Apoptosis via CD44/Ras Signaling Pathway. Digital Chinese Medicine 2020;3:297-308. [DOI: 10.1016/j.dcmed.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Fichtner M, Bozkurt E, Salvucci M, McCann C, McAllister KA, Halang L, Düssmann H, Kinsella S, Crawford N, Sessler T, Longley DB, Prehn JHM. Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant. Cell Death Dis 2020;11:1020. [PMID: 33257690 DOI: 10.1038/s41419-020-03232-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
70 Zhao L, Wei J, Wang S, Lang T, Shi X, Shan Z, Teng W. Beta-elemene inhibits differentiated thyroid carcinoma metastasis by reducing cellular proliferation, metabolism and invasion ability. Ann Transl Med 2020;8:1232. [PMID: 33178764 DOI: 10.21037/atm-20-4460] [Reference Citation Analysis]
71 Lee JH, Park SY, Hwang W, Sung JY, Cho ML, Shim J, Kim YN, Yoon K. Isoharringtonine Induces Apoptosis of Non-Small Cell Lung Cancer Cells in Tumorspheroids via the Intrinsic Pathway. Biomolecules 2020;10:E1521. [PMID: 33172112 DOI: 10.3390/biom10111521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
72 Qiu C, Zhang X, Huang B, Wang S, Zhou W, Li C, Li X, Wang J, Yang N. Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma. Onco Targets Ther 2020;13:10631-40. [PMID: 33116640 DOI: 10.2147/OTT.S272312] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
73 Ramadan FHJ, Szabo A, Kovacs D, Takatsy A, Bognar R, Gallyas F Jr, Bognar Z. Involvement of Mitochondrial Mechanisms in the Cytostatic Effect of Desethylamiodarone in B16F10 Melanoma Cells. Int J Mol Sci 2020;21:E7346. [PMID: 33027919 DOI: 10.3390/ijms21197346] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Nejabat M, Soltani F, Alibolandi M, Nejabat M, Abnous K, Hadizadeh F, Ramezani M. Smac peptide and doxorubicin-encapsulated nanoparticles: design, preparation, computational molecular approach and in vitro studies on cancer cells. J Biomol Struct Dyn 2020;:1-13. [PMID: 32912085 DOI: 10.1080/07391102.2020.1819420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
75 Shahar N, Larisch S. Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance. Drug Resistance Updates 2020;52:100712. [DOI: 10.1016/j.drup.2020.100712] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 14.7] [Reference Citation Analysis]
76 Miles MA, Hawkins CJ. In vitro analysis reveals necroptotic signaling does not provoke DNA damage or HPRT mutations. Cell Death Dis 2020;11:680. [PMID: 32826875 DOI: 10.1038/s41419-020-02879-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Ma Z, Tang X, Gao Y, Wang H, Yu P, Liu R. Combined Extracts of Epimedii Folium and Ligustri Lucidi Fructus with Budesonide Attenuate Airway Remodeling in the Asthmatic Rats by Regulating Apoptosis and Autophagy. Evid Based Complement Alternat Med 2020;2020:2319409. [PMID: 32831860 DOI: 10.1155/2020/2319409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
78 Zhao Y, Jiang WJ, Ma L, Lin Y, Wang XB. Voltage-dependent anion channels mediated apoptosis in refractory epilepsy. Open Med (Wars) 2020;15:745-53. [PMID: 33336032 DOI: 10.1515/med-2020-0113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Macejová M, Sačková V, Hradická P, Jendželovský R, Demečková V, Fedoročko P. Combination of photoactive hypericin and Manumycin A exerts multiple anticancer effects on oxaliplatin-resistant colorectal cells. Toxicology in Vitro 2020;66:104860. [DOI: 10.1016/j.tiv.2020.104860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
80 Mcmullen M, Madariaga A, Lheureux S. New approaches for targeting platinum-resistant ovarian cancer. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.08.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
81 Nejabat M, Eisvand F, Soltani F, Alibolandi M, Mohammad Taghdisi S, Abnous K, Hadizadeh F, Ramezani M. Combination therapy using Smac peptide and doxorubicin-encapsulated MUC 1-targeted polymeric nanoparticles to sensitize cancer cells to chemotherapy: An in vitro and in vivo study. Int J Pharm 2020;587:119650. [PMID: 32679263 DOI: 10.1016/j.ijpharm.2020.119650] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
82 Ren G, Hao X, Yang S, Chen J, Qiu G, Ang KP, Mohd Tamrin MI. 10H-3,6-Diazaphenothiazines triggered the mitochondrial-dependent and cell death receptor-dependent apoptosis pathways and further increased the chemosensitivity of MCF-7 breast cancer cells via inhibition of AKT1 pathways. J Biochem Mol Toxicol 2020;:e22544. [PMID: 32619082 DOI: 10.1002/jbt.22544] [Reference Citation Analysis]
83 Mir SM, Yousefi B, Marjani A, Rahimi M, Qujeq D. The Sensitization of Melatonin in Osteosarcoma Cells by Suppression of Anti-Apoptotic Proteins. Pharm Sci 2020;26:159-64. [DOI: 10.34172/ps.2020.3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
84 De Marco R, Rampazzo E, Zhao J, Prodi L, Paolillo M, Picchetti P, Gallo F, Calonghi N, Gentilucci L. Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein. Nanomaterials (Basel) 2020;10:E1211. [PMID: 32575872 DOI: 10.3390/nano10061211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Kuo Y, Rajesh R. Biomaterial-based drug delivery systems used to improve chemotherapeutic activity of pharmaceuticals and to target inhibitors of apoptosis proteins. Journal of the Taiwan Institute of Chemical Engineers 2020;111:1-10. [DOI: 10.1016/j.jtice.2020.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Soto-Mercado V, Mendivil-Perez M, Jimenez-Del-Rio M, Fox JE, Velez-Pardo C. Cannabinoid CP55940 selectively induces apoptosis in Jurkat cells and in ex vivo T-cell acute lymphoblastic leukemia through H2O2 signaling mechanism. Leuk Res 2020;95:106389. [PMID: 32540572 DOI: 10.1016/j.leukres.2020.106389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
87 Liu T, Wu Z, He Y, Xiao Y, Xia C. Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy. Eur J Med Chem 2020;201:112446. [PMID: 32563811 DOI: 10.1016/j.ejmech.2020.112446] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
88 Li Z, Zhu L, Liu W, Zheng Y, Li X, Ye J, Li B, Chen H, Gao Y. Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer. Acta Biomater 2020;107:242-59. [PMID: 32151700 DOI: 10.1016/j.actbio.2020.03.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
89 Liang L, Cheng C, Hu G, Wang X, Liu J, Yan Z, Zeng W, Xia Y. TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating cIAP1 Signals. Front Oncol 2020;10:439. [PMID: 32351884 DOI: 10.3389/fonc.2020.00439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
90 Łupicka-Słowik A, Psurski M, Grzywa R, Cuprych M, Ciekot J, Goldeman W, Wojaczyńska E, Wojaczyński J, Oleksyszyn J, Sieńczyk M. Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists. Invest New Drugs 2020;38:1350-64. [PMID: 32270379 DOI: 10.1007/s10637-020-00923-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
91 Luo Y, Dong Y, Liang S, Yuan L, Men H, Zhang S, Tian S, Fu X, Dong B, Meng M. CpG Oligodeoxynucleotide Promotes Apoptosis of Human Bladder Cancer T24 Cells Via Inhibition of the Antiapoptotic Factors. Technol Cancer Res Treat 2019;18:1533033819873636. [PMID: 31547786 DOI: 10.1177/1533033819873636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Fu G, Xu Z, Chen X, Pan H, Wang Y, Jin B. CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation. J Cancer 2020;11:2408-20. [PMID: 32201512 DOI: 10.7150/jca.35372] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
93 Hofmann MH, Mani R, Engelhardt H, Impagnatiello MA, Carotta S, Kerenyi M, Lorenzo-Herrero S, Böttcher J, Scharn D, Arnhof H, Zoephel A, Schnitzer R, Gerstberger T, Sanderson MP, Rajgolikar G, Goswami S, Vasu S, Ettmayer P, Gonzalez S, Pearson M, McConnell DB, Kraut N, Muthusamy N, Moll J. Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance. Mol Cancer Ther 2020;19:1018-30. [PMID: 32024684 DOI: 10.1158/1535-7163.MCT-19-0789] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
94 Schnoell J, Kadletz L, Jank BJ, Oberndorfer F, Brkic FF, Gurnhofer E, Cede J, Seemann R, Kenner L, Heiduschka G. Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause-specific survival. Clin Otolaryngol 2020;45:364-9. [PMID: 31984681 DOI: 10.1111/coa.13509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
95 Yang LT, Ma F, Zeng HT, Zhao M, Zeng XH, Liu ZQ, Yang PC. Restoration of Mal overcomes the defects of apoptosis in lung cancer cells. PLoS One 2020;15:e0227634. [PMID: 31978067 DOI: 10.1371/journal.pone.0227634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
96 Liang J, Zhao W, Tong P, Li P, Zhao Y, Li H, Liang J. Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer. BMC Med Genomics 2020;13:7. [PMID: 31964418 DOI: 10.1186/s12920-020-0661-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
97 Madigan JP, Robey RW, Poprawski JE, Huang H, Clarke CJ, Gottesman MM, Cabot MC, Rosenberg DW. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer. Exp Cell Res 2020;388:111860. [PMID: 31972222 DOI: 10.1016/j.yexcr.2020.111860] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
98 Michie J, Kearney CJ, Hawkins ED, Silke J, Oliaro J. The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy. Cells 2020;9:E207. [PMID: 31947615 DOI: 10.3390/cells9010207] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
99 Junaid M, Akter Y, Afrose SS, Tania M, Khan MA. Apoptotic Cell Death: Important Cellular Process as Chemotherapeutic Target. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models 2020. [DOI: 10.1007/978-981-15-7586-0_4] [Reference Citation Analysis]
100 Zheng W, Ge D, Meng G. Reversing microtubule-directed chemotherapeutic drug resistance by co-delivering α2β1 inhibitor and paclitaxel with nanoparticles in ovarian cancer. Cell Biol Int 2020;44:610-20. [PMID: 31743535 DOI: 10.1002/cbin.11261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
101 Perumal PO, Mhlanga P, Somboro AM, Amoako DG, Khumalo HM, Khan RM. Cytoproliferative and Anti-Oxidant Effects Induced by Tannic Acid in Human Embryonic Kidney (Hek-293) Cells. Biomolecules 2019;9:E767. [PMID: 31766707 DOI: 10.3390/biom9120767] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
102 Sun C, Chesnokov V, Larson G, Itakura K. Glucosamine Enhances TRAIL-Induced Apoptosis in the Prostate Cancer Cell Line DU145. Medicines (Basel) 2019;6:E104. [PMID: 31618900 DOI: 10.3390/medicines6040104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
103 Schmidt N, Kowald L, van Wijk SJL, Fulda S. Differential involvement of TAK1, RIPK1 and NF-κB signaling in Smac mimetic-induced cell death in breast cancer cells. Biol Chem 2019;400:171-80. [PMID: 30391931 DOI: 10.1515/hsz-2018-0324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
104 Muñoz D, Brucoli M, Zecchini S, Sandoval-Hernandez A, Arboleda G, Lopez-Vallejo F, Delgado W, Giovarelli M, Coazzoli M, Catalani E, De Palma C, Perrotta C, Cuca L, Clementi E, Cervia D. XIAP as a Target of New Small Organic Natural Molecules Inducing Human Cancer Cell Death. Cancers (Basel) 2019;11:E1336. [PMID: 31505859 DOI: 10.3390/cancers11091336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
105 Wong SHM, Kong WY, Fang CM, Loh HS, Chuah LH, Abdullah S, Ngai SC. The TRAIL to cancer therapy: Hindrances and potential solutions. Crit Rev Oncol Hematol 2019;143:81-94. [PMID: 31561055 DOI: 10.1016/j.critrevonc.2019.08.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 14.5] [Reference Citation Analysis]
106 Antunes-Ricardo M, Hernández-Reyes A, Uscanga-Palomeque AC, Rodríguez-Padilla C, Martínez-Torres AC, Gutiérrez-Uribe JA. Isorhamnetin glycoside isolated from Opuntia ficus-indica (L.) MilI induces apoptosis in human colon cancer cells through mitochondrial damage. Chem Biol Interact 2019;310:108734. [PMID: 31276661 DOI: 10.1016/j.cbi.2019.108734] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
107 Poma P, Labbozzetta M, McCubrey JA, Ramarosandratana AV, Sajeva M, Zito P, Notarbartolo M. Antitumor Mechanism of the Essential Oils from Two Succulent Plants in Multidrug Resistance Leukemia Cell. Pharmaceuticals (Basel) 2019;12:E124. [PMID: 31454963 DOI: 10.3390/ph12030124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
108 Yuan J, Yin Z, Tan L, Zhu W, Tao K, Wang G, Shi W, Gao J. Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer. Cancer Letters 2019;457:28-39. [DOI: 10.1016/j.canlet.2019.05.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
109 Moertl S, Payer S, Kell R, Winkler K, Anastasov N, Atkinson MJ. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells. Int J Mol Sci 2019;20:E3259. [PMID: 31269745 DOI: 10.3390/ijms20133259] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
110 Varghese E, Samuel SM, Sadiq Z, Kubatka P, Liskova A, Benacka J, Pazinka P, Kruzliak P, Büsselberg D. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection. Int J Mol Sci 2019;20:E3017. [PMID: 31226817 DOI: 10.3390/ijms20123017] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 17.0] [Reference Citation Analysis]
111 Guo H, Treude F, Krämer OH, Lüscher B, Hartkamp J. PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1. Sci Rep 2019;9:8755. [PMID: 31217499 DOI: 10.1038/s41598-019-45209-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
112 Li W, Turaga RC, Li X, Sharma M, Enadi Z, Dunham Tompkins SN, Hardy KC, Mishra F, Tsao J, Liu ZR, Fan D, Luo M. Overexpression of Smac by an Armed Vesicular Stomatitis Virus Overcomes Tumor Resistance. Mol Ther Oncolytics 2019;14:188-95. [PMID: 31312717 DOI: 10.1016/j.omto.2019.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
113 Chang MM, Pan BS, Wang CY, Huang BM. Cordycepin-induced unfolded protein response-dependent cell death, and AKT/MAPK-mediated drug resistance in mouse testicular tumor cells. Cancer Med 2019;8:3949-64. [PMID: 31145545 DOI: 10.1002/cam4.2285] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
114 Dai P, He Y, Luo G, Deng J, Jiang N, Fang T, Li Y, Cheng Y. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis. J Cell Biochem 2019;120:16798-810. [PMID: 31090103 DOI: 10.1002/jcb.28938] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
115 Kim JL, Park SH, Jeong S, Kim BR, Na YJ, Jo MJ, Jeong YA, Yun HK, Kim DY, Kim BG, You S, Oh SC, Lee DH. Sea Cucumber (Stichopus japonicas) F2 Enhanced TRAIL-Induced Apoptosis via XIAP Ubiquitination and ER Stress in Colorectal Cancer Cells. Nutrients 2019;11:E1061. [PMID: 31083595 DOI: 10.3390/nu11051061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
116 Eberle J. Countering TRAIL Resistance in Melanoma. Cancers (Basel) 2019;11:E656. [PMID: 31083589 DOI: 10.3390/cancers11050656] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
117 Tomic D, Pirkic B, Skala K, Kranjcevic L. Predicting the effectiveness of multi-drug cancer therapies. 2019 42nd International Convention on Information and Communication Technology, Electronics and Microelectronics (MIPRO) 2019. [DOI: 10.23919/mipro.2019.8757131] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Xi M, Chen Y, Yang H, Xu H, Du K, Wu C, Xu Y, Deng L, Luo X, Yu L, Wu Y, Gao X, Cai T, Chen B, Shen R, Sun H. Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation. Eur J Med Chem 2019;174:159-80. [PMID: 31035238 DOI: 10.1016/j.ejmech.2019.04.036] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
119 Xavier NM, Goncalves-pereira R, Jorda R, Hendrychová D, Oliveira MC. Novel dodecyl-containing azido and glucuronamide-based nucleosides exhibiting anticancer potential. Pure and Applied Chemistry 2019;91:1085-105. [DOI: 10.1515/pac-2019-0106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
120 Wang S, Liao H, Li F, Ling D. A mini-review and perspective on ferroptosis-inducing strategies in cancer therapy. Chinese Chemical Letters 2019;30:847-52. [DOI: 10.1016/j.cclet.2019.03.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
121 Prabhu KS, Siveen KS, Kuttikrishnan S, Jochebeth A, Ali TA, Elareer NR, Iskandarani A, Quaiyoom Khan A, Merhi M, Dermime S, El-Elimat T, Oberlies NH, Alali FQ, Steinhoff M, Uddin S. Greensporone A, a Fungal Secondary Metabolite Suppressed Constitutively Activated AKT via ROS Generation and Induced Apoptosis in Leukemic Cell Lines. Biomolecules 2019;9:E126. [PMID: 30934922 DOI: 10.3390/biom9040126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
122 Zhao D, Song H, Zhou X, Chen Y, Liu Q, Gao X, Zhu X, Chen D. Novel facile thermosensitive hydrogel as sustained and controllable gene release vehicle for breast cancer treatment. Eur J Pharm Sci 2019;134:145-52. [PMID: 30926401 DOI: 10.1016/j.ejps.2019.03.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
123 Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa AE. NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity. J Cell Physiol 2019;234:17187-204. [DOI: 10.1002/jcp.28504] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
124 Abner E, Jordan A. HIV "shock and kill" therapy: In need of revision. Antiviral Res 2019;166:19-34. [PMID: 30914265 DOI: 10.1016/j.antiviral.2019.03.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 20.5] [Reference Citation Analysis]
125 Griffioen AW, Nowak-sliwinska P. Cell death rocks. Apoptosis 2019;24:205-7. [DOI: 10.1007/s10495-019-01516-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
126 Giannopoulou AF, Konstantakou EG, Velentzas AD, Avgeris SN, Avgeris M, Papandreou NC, Zoi I, Filippa V, Katarachia S, Lampidonis AD, Prombona A, Syntichaki P, Piperi C, Basdra EK, Iconomidou V, Papadavid E, Anastasiadou E, Papassideri IS, Papavassiliou AG, Voutsinas GE, Scorilas A, Stravopodis DJ. Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients. Int J Mol Sci 2019;20:E937. [PMID: 30795533 DOI: 10.3390/ijms20040937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
127 Cossu F, Milani M, Mastrangelo E, Lecis D. Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment. Comput Struct Biotechnol J 2019;17:142-50. [PMID: 30766663 DOI: 10.1016/j.csbj.2019.01.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 11.5] [Reference Citation Analysis]
128 Abotaleb M, Samuel SM, Varghese E, Varghese S, Kubatka P, Liskova A, Büsselberg D. Flavonoids in Cancer and Apoptosis. Cancers (Basel) 2018;11:E28. [PMID: 30597838 DOI: 10.3390/cancers11010028] [Cited by in Crossref: 277] [Cited by in F6Publishing: 289] [Article Influence: 55.4] [Reference Citation Analysis]
129 Nalli AD, Brown LE, Thomas CL, Sayers TJ, Porco JA Jr, Henrich CJ. Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs. Sci Rep 2018;8:17519. [PMID: 30504817 DOI: 10.1038/s41598-018-35908-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
130 Martínez-García D, Manero-Rupérez N, Quesada R, Korrodi-Gregório L, Soto-Cerrato V. Therapeutic strategies involving survivin inhibition in cancer. Med Res Rev 2019;39:887-909. [PMID: 30421440 DOI: 10.1002/med.21547] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 14.6] [Reference Citation Analysis]
131 Li Y, Liu C, Xu X, Lu X, Luo J, Gray B, Pak KY, Cheng J, Zhang Y. [99mTc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy. Nuclear Medicine and Biology 2018;66:18-25. [DOI: 10.1016/j.nucmedbio.2018.07.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
132 Ramírez-rivera S, Pizarro S, Gallardo M, Gajardo F, Delgadillo A, De La Fuente-ortega E, Macdonnell F, Bernal G. Anticancer activity of two novel ruthenium compounds in gastric cancer cells. Life Sciences 2018;213:57-65. [DOI: 10.1016/j.lfs.2018.10.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
133 Qi C, Gao W, Guan D, Wang J, Liu M, Chen C, Zhu H, Zhou Y, Lai Y, Hu Z, Zhou Q, Zhang Y. Butenolides from a marine-derived fungus Aspergillus terreus with antitumor activities against pancreatic ductal adenocarcinoma cells. Bioorg Med Chem 2018;26:5903-10. [PMID: 30392953 DOI: 10.1016/j.bmc.2018.10.040] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
134 Favero G, Moretti E, Bonomini F, Reiter RJ, Rodella LF, Rezzani R. Promising Antineoplastic Actions of Melatonin. Front Pharmacol 2018;9:1086. [PMID: 30386235 DOI: 10.3389/fphar.2018.01086] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
135 Miles MA, Hawkins CJ. Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways. Sci Rep 2018;8:14421. [PMID: 30258062 DOI: 10.1038/s41598-018-32517-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
136 Li N, Han M, Zhou N, Tang Y, Tang XS. MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2). Med Sci Monit 2018;24:5960-72. [PMID: 30147110 DOI: 10.12659/MSM.909458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
137 Li D, Ni T, Tao L, Jin F, Wang H, Feng J, Zhu G, Qian Y, Ding Y, Sunagagwa M, Liu Y. Jinlong Capsule (JLC) inhibits proliferation and induces apoptosis in human gastric cancer cells in vivo and in vitro. Biomed Pharmacother 2018;107:738-45. [PMID: 30138896 DOI: 10.1016/j.biopha.2018.08.049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
138 Wang N, Zhang B, Jin F, Gao D, Liu F, Liu H, Jiang Y. Combing metabolomics with bioanalysis methods to study the antitumor mechanism of the new acridone derivative 8q on CCRF-CEM cells: 8q induced mitochondrial-mediated apoptosis and targeted the PI3K/AKT/FOXO1 pathway. J Pharm Biomed Anal 2018;160:314-22. [PMID: 30114609 DOI: 10.1016/j.jpba.2018.08.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
139 Han Q, Ma Y, Wang H, Dai Y, Chen C, Liu Y, Jing L, Sun X. Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis. J Transl Med. 2018;16:201. [PMID: 30029665 DOI: 10.1186/s12967-018-1580-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
140 Prabhu KS, Siveen KS, Kuttikrishnan S, Iskandarani AN, Khan AQ, Merhi M, Omri HE, Dermime S, El-Elimat T, Oberlies NH, Alali FQ, Uddin S. Greensporone C, a Freshwater Fungal Secondary Metabolite Induces Mitochondrial-Mediated Apoptotic Cell Death in Leukemic Cell Lines. Front Pharmacol 2018;9:720. [PMID: 30061828 DOI: 10.3389/fphar.2018.00720] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
141 Zaki I, Abdelhameid MK, El-Deen IM, Abdel Wahab AHA, Ashmawy AM, Mohamed KO. Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line. Eur J Med Chem 2018;156:563-79. [PMID: 30025350 DOI: 10.1016/j.ejmech.2018.07.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
142 Min KA, Maharjan P, Ham S, Shin MC. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy. Arch Pharm Res 2018;41:594-616. [PMID: 29804279 DOI: 10.1007/s12272-018-1038-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
143 Chen C, Lu L, Yan S, Yi H, Yao H, Wu D, He G, Tao X, Deng X. Autophagy and doxorubicin resistance in cancer. Anticancer Drugs 2018;29:1-9. [PMID: 29099416 DOI: 10.1097/CAD.0000000000000572] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 17.6] [Reference Citation Analysis]
144 Li M, Wu XM, Gao J, Yang F, Zhang CL, Ke K, Wang YC, Zheng YS, Yao JF, Guan YY, Chen X, Chen J, Liu XL, Yang XY. Mutations in the P10 region of procaspase-8 lead to chemotherapy resistance in acute myeloid leukemia by impairing procaspase-8 dimerization. Cell Death Dis 2018;9:516. [PMID: 29725008 DOI: 10.1038/s41419-018-0511-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
145 Taveira GB, Mello ÉO, Souza SB, Monteiro RM, Ramos AC, Carvalho AO, Rodrigues R, Okorokov LA, Gomes VM. Programmed cell death in yeast by thionin-like peptide from Capsicum annuum fruits involving activation of caspases and extracellular H+ flux. Biosci Rep 2018;38:BSR20180119. [PMID: 29599127 DOI: 10.1042/BSR20180119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
146 Pan W, Luo Q, Yan X, Yuan L, Yi H, Zhang L, Li B, Zhang Y, Sun J, Qiu MZ, Yang DJ. A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity. Biochem Pharmacol 2018;154:127-35. [PMID: 29679556 DOI: 10.1016/j.bcp.2018.04.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
147 Tan SK, Jermakowicz A, Mookhtiar AK, Nemeroff CB, Schürer SC, Ayad NG. Drug Repositioning in Glioblastoma: A Pathway Perspective. Front Pharmacol 2018;9:218. [PMID: 29615902 DOI: 10.3389/fphar.2018.00218] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 11.8] [Reference Citation Analysis]
148 Karlık Ö, Balcıoğlu S, Karataş MO, Ateş B, Alıcı B, Özdemir N. Synthesis, structural characterization and cytotoxicity studies of T-shaped silver(I) complexes derived from 1-benzyl-3H-benzimidazolium p-toluenesulfonates. Polyhedron 2018;142:63-70. [DOI: 10.1016/j.poly.2017.12.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
149 Jaafar R, Mnich K, Dolan S, Hillis J, Almanza A, Logue SE, Samali A, Gorman AM. RIP2 enhances cell survival by activation of NF-ĸB in triple negative breast cancer cells. Biochem Biophys Res Commun 2018;497:115-21. [PMID: 29421659 DOI: 10.1016/j.bbrc.2018.02.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
150 Faccion RS, Bernardo PS, de Lopes GPF, Bastos LS, Teixeira CL, de Oliveira JA, Fernandes PV, Dubois LG, Chimelli L, Maia RC. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors. Cell Oncol 2018;41:141-57. [DOI: 10.1007/s13402-017-0361-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
151 Peng Z, Zhang C, Zhou W, Wu C, Zhang Y. The STAT3/NFIL3 signaling axis-mediated chemotherapy resistance is reversed by Raddeanin A via inducing apoptosis in choriocarcinoma cells. J Cell Physiol 2018;233:5370-82. [PMID: 29215740 DOI: 10.1002/jcp.26362] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
152 Carè A, Bellenghi M, Matarrese P, Gabriele L, Salvioli S, Malorni W. Sex disparity in cancer: roles of microRNAs and related functional players. Cell Death Differ 2018;25:477-85. [PMID: 29352271 DOI: 10.1038/s41418-017-0051-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 10.6] [Reference Citation Analysis]
153 Ježek J, Cooper KF, Strich R. Reactive Oxygen Species and Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and Cancer Progression. Antioxidants (Basel) 2018;7:E13. [PMID: 29337889 DOI: 10.3390/antiox7010013] [Cited by in Crossref: 222] [Cited by in F6Publishing: 241] [Article Influence: 44.4] [Reference Citation Analysis]
154 Li M, Yao J, Zhang X, Chen X, Chen J, Guan Y, Yang X. Q482H mutation of procaspase-8 in acute myeloid leukemia abolishes caspase-8-mediated apoptosis by impairing procaspase-8 dimerization. Biochemical and Biophysical Research Communications 2018;495:1376-82. [DOI: 10.1016/j.bbrc.2017.11.168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
155 Xu F, Zhong H, Chang Y, Li D, Jin H, Zhang M, Wang H, Jiang C, Shen Y, Huang Y. Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites. Biomaterials 2018;158:56-73. [PMID: 29304403 DOI: 10.1016/j.biomaterials.2017.12.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
156 Treshalina HM, Romanenko VI, Kaluzhny DN, Treshalin MI, Nikitin AA, Tikhomirov AS, Shchekotikhin AE. Development and pharmaceutical evaluation of the anticancer Anthrafuran/Cavitron complex, a prototypic parenteral drug formulation. European Journal of Pharmaceutical Sciences 2017;109:631-7. [DOI: 10.1016/j.ejps.2017.09.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
157 Dubuisson A, Micheau O. Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy. Antibodies (Basel) 2017;6:E16. [PMID: 31548531 DOI: 10.3390/antib6040016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
158 Handayani S, Susidarti RA, Jenie RI, Meiyanto E. Two Active Compounds from Caesalpinia sappan L. in Combination with Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest on WiDr Cells. Adv Pharm Bull 2017;7:375-80. [PMID: 29071219 DOI: 10.15171/apb.2017.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]